Revenue segments as reported by the company.

Net revenue, before excise taxes

Excise taxes

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

Research and development

General and administrative

Restructuring costs

Share-based payments

Depreciation and amortization

Impairment loss on goodwill and indefinite-lived intangible assets

Impairment loss on long-lived assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cronos Group

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.

Arena Pharmaceuticals

Canopy Growth

Cardiff Oncology

GrowGeneration Corp

Hawaiian Electric Industries

Innovative Industrial Properties

Neptune Wellness Solutions Inc.

Village Farms International

22nd Century Group

Zynerba Pharmaceuticals

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and look ahead to how the cannabis industry continues to take shape in 2021.

Smoked! How the Hottest Cannabis Stocks Fared This Week

Aurora Cannabis

Amplify Alternative Harvest ETF

Momentum traders are moving into marijuana stocks and their charts look great. Here are top picks in the industry if you want to play along.

3 Pot Plays That Are Lighting Up With Momentum

Cannabinoid company Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) is amending its previous partnership agreement with Ginkgo Bioworks, Inc., a company involved in cell programming. The amendment allows Cronos to start commercializing products with cultured cannabinoids before meeting the initially set productivity goals.

Cronos Group, Ginkgo Bioworks Modify Agreement To Speed Up Commercialization of Cultured Cannabinoids

Shares of this troubled marijuana grower are finally on the move, but does it mean you should buy them?

Up 20% Over a Few Days, Is Cronos a Stock You Can Count On?

Canadian cannabis company Cronos Group Inc. said Friday it has amended its agreement with Ginkgo Bioworks Inc. to accelerate the commercialization of cultured cannabinoids at scale. Cronos has had a research partnership with Ginkgo for several years with the aim of producing rare strains of cannabis that feature some of the 100 different cannabinoids, the compounds in the plant.

Canadian cannabis company Cronos amends agreement with Ginkgo, to issue up to 14.7 million shares

BOSTON and TORONTO, June 04, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group”), an innovative global cannabinoid company, and Ginkgo Bioworks, Inc. (“Ginkgo”), which is building the leading horizontal platform for cell programming, today announced an amended collaboration and license agreement (the “Amended Agreement”) that will enable the companies to accelerate the commercialization of cultured cannabinoids at scale.

Cronos Group and Ginkgo Bioworks Amend Agreement to Accelerate Commercialization of Cultured Cannabinoids and Cronos Group Begins Commercial Production of CBG

SNDL Inc.

Not all cannabis stocks will have investors seeing green.

3 Pot Stocks to Avoid Like the Plague in June

Tilray Brands

The marijuana industry is now an exciting place for traditional investors. If you discover the legal grey areas of this space, it could mean big things for your portfolio.

Marijuana Stocks on the Move

After struggling in recent months, companies that focus on the booming marijuana sector could be primed for a takeoff.

Cannabis stocks could be primed for a breakout thanks to Reddit and Amazon

OrganiGram Holdings Inc.

It's bad news all around in the marijuana industry today.

Why Canopy Growth Stock Crashed Today and Took OrganiGram and Cronos Down With It

2 Canadian Marijuana Stocks To Add To Your June Watchlist The post 2 Top Canadian Marijuana Stocks To Watch In June 2021 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

2 Top Canadian Marijuana Stocks To Watch In June 2021

Cronos (CRON) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Cronos (CRON) Moves 15.2% Higher: Will This Strength Last?

More mergers could mean more profits for shareholders.

Why Sundial, Aurora Cannabis, Cronos Group, and Other Marijuana Stocks Surged Today

HEXO Corp

Wall Street closed the month on a positive note.

Why Pot Stocks Led Markets Higher Into the Holiday Weekend

Horizon Acquisition Corp II

Ammo

Simon Property Group

A cheap price can sometimes disguise an outstanding opportunity.

4 Great Stocks Under $10 a Share

Are These Canadian Cannabis Stocks At Good Levels To Start A Position? The post Canadian Marijuana Stocks To Buy? 2 That May Produce Gains From Recent Levels appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Canadian Marijuana Stocks To Buy? 2 That May Produce Gains From Recent Levels

The cannabis industry is faced with two main objectives: Finding the right product to competitively grow and then finding the right place to actually set up operations. Sale-leaseback options are a financing tool cannabis companies are increasingly using in their pursuit of non-traditional financing.

Sale/Lease Buyback Model - Why It's the Hottest Funding Method for Cannabis Properties Now and Why It May Soon Not Be So Hot…

Could These Marijuana Stocks Deliver Gains In May? The post Are These The Best Canadian Marijuana Stocks To Buy? 2 To Watch Right Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Are These The Best Canadian Marijuana Stocks To Buy? 2 To Watch Right Now

One of the most significant growth trends in the world today is in CBD products. This was also one of the most significant market booms of the past half-decade.

Is it Time to Start Watching CBD Stocks Like CWBHF, MJNA, RLBD, and CRON?

Curaleaf Holdings, Inc.

Akerna Corp

Cambria Cannabis ETF

AdvisorShares Pure Cannabis ETF 

Canadian marijuana stocks have fallen from their February highs. But one player in the industry got a lot bigger after a merger deal.

Are Any Canadian Marijuana Stocks Good Buys As Earnings Disappoint?

Low volatility weed stocks that are best positioned to benefit from industry tailwinds and potential cannabis legalization at federal level. The post 4 of the Least Volatile Weed Stocks appeared first on InvestorPlace.

4 of the Least Volatile Weed Stocks

These Marijuana Stocks Look To Reach Better Market Levels In May The post These Marijuana Stocks Are Working To Build More Market Momentum appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

These Marijuana Stocks Are Working To Build More Market Momentum

TORONTO, May 10, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, will speak at Canaccord Genuity's 5th Annual Global Cannabis Conference on Tuesday, May 11, 2021 at 2:30 p.m. EDT.

Cronos Group Inc. to Participate in Canaccord Genuity's 5th Annual Global Cannabis Conference on May 11, 2021

Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) released a Marketing Code addressing the issue of targeting young people who are below the legal age for adult-use cannabis consumption. Kurt Schmidt, President and CEO of the Toronto-based Cronos Group, emphasized a need for standards and principles that will elevate industry practices.

Cronos Group Encourages Responsibility In Cannabis Industry, Introduces Marketing Code

TORONTO and LOS ANGELES, May 10, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today released a Marketing Code designed to responsibly move the emerging cannabis industry forward. Cronos Group believes that those below the legal age of consumption should not be targeted in an adult-use cannabis market. Cronos Group recognizes there is a clear need for standards. That's why the Company proactively created its own and is sharing its principles publicly as a resource for the industry and policymakers.

Cronos Group Launches Marketing Code to Drive Responsibility Within the Cannabis Industry

News for Cronos Group Stock (CRON)